Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADC Therapeutics SA

1.18
-0.0500-4.07%
Post-market: 1.230.0500+4.24%19:01 EDT
Volume:691.57K
Turnover:816.03K
Market Cap:116.92M
PE:-0.73
High:1.23
Open:1.19
Low:1.14
Close:1.23
Loading ...

RBC Capital Keeps Their Buy Rating on ADC Therapeutics (ADCT)

TIPRANKS
·
Yesterday

ADC Therapeutics SA (ADCT) Q4 2024 Earnings Call Highlights: Navigating Challenges and ...

GuruFocus.com
·
01 Apr

ADC Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
28 Mar

ADC Therapeutics SA reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

BRIEF-ADC Therapeutics Q4 Net Income USD -30.727 Million

Reuters
·
27 Mar

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
27 Mar

ADC Therapeutics Says $250.9M In Cash As Of December 31, 2024 Is Expected To Provide Cash Runway Into The Second Half Of 2026

Benzinga
·
27 Mar

ADC Therapeutics Q4 2024 Adj EPS $(0.25) Beats $(0.41) Estimate, Sales $16.91M Miss $19.01M Estimate

Benzinga
·
27 Mar

ADC Therapeutics Q4 Income From Operations USD -32.436 Million

THOMSON REUTERS
·
27 Mar

ADC Therapeutics Sa - $250.9M in Cash as of December 31, 2024, Provides Runway Expected to Fund Operations Into Second Half of 2026

THOMSON REUTERS
·
27 Mar

Press Release: ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update

Dow Jones
·
27 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar

ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025

PR Newswire
·
26 Mar

ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025

PR Newswire
·
20 Mar

ADC Therapeutics SA expected to post a loss of 42 cents a share - Earnings Preview

Reuters
·
07 Mar

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
27 Feb

Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
25 Feb

ADC Therapeutics Is Maintained at Overweight by Stephens & Co.

Dow Jones
·
24 Feb

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

PR Newswire
·
04 Feb

ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference

PR Newswire
·
30 Jan